Supreme Court On Pharmaceutical Companies
- All
- News
-
1,000 Crore Freebies For Doctors To Prescribe DOLO, Supreme Court Told
The Supreme Court on Thursday asked the Centre to file its response within 10 days on a PIL seeking directions to make pharmaceutical companies liable for giving freebies to doctors as an incentive to prescribe their drugs.
-
Zydus Cadila Shot For 12-18 Soon, Centre Informs Supreme Court
A new coronavirus vaccine developed by Indian pharmaceutical company Zydus Cadila will be available soon for those between 12-18 years of age, the central government said in an affidavit to the Supreme Court on Saturday.
-
Supreme Court Asks Andhra High Court to Decide on Ranbaxy-Sun Pharma Merger
Hearing appeals filed by Sun Pharmaceutical, Ranbaxy Laboratories and Daiichi Sankyo Company against HC interim order, a bench of justices B S Chauhan and A K Sikri asked the HC to decide the issue and posted the case for hearing on May 27.
-
Drug patents: A showdown for pharma cos in Supreme Court
The Supreme Court hearing on drug patents pits Swiss drugmaker Novartis AG against India's patent office, which has refused to grant a patent on the company's cancer drug Glivec on the grounds that it is not a new medicine but an amended version of a known compound.
-
1,000 Crore Freebies For Doctors To Prescribe DOLO, Supreme Court Told
The Supreme Court on Thursday asked the Centre to file its response within 10 days on a PIL seeking directions to make pharmaceutical companies liable for giving freebies to doctors as an incentive to prescribe their drugs.
-
Zydus Cadila Shot For 12-18 Soon, Centre Informs Supreme Court
A new coronavirus vaccine developed by Indian pharmaceutical company Zydus Cadila will be available soon for those between 12-18 years of age, the central government said in an affidavit to the Supreme Court on Saturday.
-
Supreme Court Asks Andhra High Court to Decide on Ranbaxy-Sun Pharma Merger
Hearing appeals filed by Sun Pharmaceutical, Ranbaxy Laboratories and Daiichi Sankyo Company against HC interim order, a bench of justices B S Chauhan and A K Sikri asked the HC to decide the issue and posted the case for hearing on May 27.
-
Drug patents: A showdown for pharma cos in Supreme Court
The Supreme Court hearing on drug patents pits Swiss drugmaker Novartis AG against India's patent office, which has refused to grant a patent on the company's cancer drug Glivec on the grounds that it is not a new medicine but an amended version of a known compound.
